Toll Free : 1-800-489-3075

Global Triptorelin Pamoate Market Forecast and Analysis 2016-2021

Choose License Type
Published by:

Gen Consulting Company



Published On:

May 2016

No of pages:


Report Format:

Electronic (PDF)

This report provides detailed analysis of worldwide markets for Triptorelin Pamoate from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Triptorelin Pamoate market and further lays out an analysis of the factors influencing the supply/demand for Triptorelin Pamoate, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy for gender identity disorder.

GCC's report, Global Triptorelin Pamoate Market Forecast and Analysis 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Triptorelin Pamoate market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Triptorelin Pamoate market areDebiopharm Group (Switzerland), Bachem (Switzerland), Ipsen (France), Teva API (Israel).

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Triptorelin Pamoate industry has been provided.